Michael Andria
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Neutropenia and Cancer Infections
- Dermatology top 10%
Papers in
- Oncology 12
- Colorectal Cancer Treatments and Studies 8
- Cancer Treatment and Pharmacology 4
- Cutaneous Melanoma Detection and Management 3
-
- Cancer, Lipids, and Metabolism 4
- Cancer Genomics and Diagnostics 2
- Co-authors
- Philip J. Gold (2 shared papers)Neal J. Meropol (1 shared paper)Rebecca Blanchard (1 shared paper)Hao Wang (1 shared paper)André Rogatko (1 shared paper)Todd Hill (1 shared paper)Roland Schwarting (1 shared paper)Albert J. Kovatich (1 shared paper)
- Journals
- Journal of Clinical Oncology (9 papers)Future Oncology (2 papers)Annals of Allergy Asthma & Immunology (1 paper)Clinical Cancer Research (1 paper)American Journal of Health-System Pharmacy (1 paper)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Michael Andria
15 papers receiving 400 citations
Peers
Comparison fields: 5 of 51
- Oncology 283
- Dermatology 68
- Pharmacology 54
- Immunology and Allergy 28
- Hepatology 25
Countries citing papers authored by Michael Andria
This map shows the geographic impact of Michael Andria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Andria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Andria more than expected).
Fields of papers citing papers by Michael Andria
This network shows the impact of papers produced by Michael Andria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Andria. The network helps show where Michael Andria may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Andria, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 202 | |
| 2 | 2006 | 87 | |
| 3 | 2020 | 37 | |
| 4 | 2019 | 34 | |
| 5 | 2020 | 28 | |
| 6 | 2018 | 8 | |
| 7 | 2013 | 3 | |
| 8 | 2013 | 2 | |
| 9 | 2017 | 1 | |
| 10 | 1999 | 1 | |
| 11 | 2013 | 1 | |
| 12 | 2013 | 1 | |
| 13 | 2012 | 1 | |
| 14 | 2013 | 1 | |
| 15 | 2013 | 1 |
About Michael Andria
Michael Andria is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Dermatology and Epidemiology, having authored 15 papers that have together received 408 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (4 papers), Cancer, Lipids, and Metabolism (4 papers), Cutaneous Melanoma Detection and Management (3 papers), Nonmelanoma Skin Cancer Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (283 citations), Dermatology (68 citations), Pharmacology (54 citations), Immunology and Allergy (28 citations) and Hepatology (25 citations). Michael Andria has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Philip J. Gold, Neal J. Meropol, Rebecca Blanchard, Hao Wang, André Rogatko, Todd Hill, Roland Schwarting, Albert J. Kovatich, Neal J. Meropol and Mandeep S. Dhami. Their work appears in journals such as Journal of Clinical Oncology, Future Oncology, Annals of Allergy Asthma & Immunology, Clinical Cancer Research and American Journal of Health-System Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.